AUSTIN, Texas, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing ...

Short interest in Plus Therapeutics Inc (NASDAQ:PSTV) decreased during the last reporting period, falling from 95.43K to 53.96K. This put 0.93% of the company's publicly available shares short.

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure The flexible and expandable T7 is designed ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

Tesla, seen as a key beneficiary of the so-called 'Trump Trade' thanks in part to CEO Elon Musk, is set to open at the highest levels in more than a year.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Plus Therapeutics ( NASDAQ:PSTV ) Second Quarter 2024 Results Key Financial Results Revenue: US$1.28m (down 31% from 2Q ...